Formyl pyridine reaction with dibromopropane was controlled to obtain monosubstituted product by using excessive dibromopropane (as solvent, instead of stoichiometric ratio). The obtained salt N-alkylated product was found to be an ionic liquid after removal of solvents. In the next step, bromo group was substituted by thioacetate nucleophile in polar protic solvent (
Figure 1A). The optimized reaction conditions suited the formation of thiopyridine favorably as implied by high-yield and purity. Thiopyridine was finally used to stabilize silver nanoparticles synthesized by one phase reduction by sodium borohydride (
13).
Figure 1B describes the typical surface plasmon resonance band of the AgNPs for ThPy-conjugated AgNPs with absorption maxima at 402 nm, while 1C shows the size and morphology of spherical polydispersed nanoconjugates with the average diameter of 60 nm.
To evaluate the antibacterial effects of silver nanoparticles conjugation with thiopyridine against
E. coli, inhibition zone assay was performed. Since ThPy-AgNPs were found to display specific affinity towards Cu(I) ions and copper homeostasis plays a pivotal role in the defense mechanism of
E. coli, we aimed to test the effects of intracellular interactions of Cu(I) and ThPy-AgNPs on their antibacterial potency. Bacteria were treated with multiple doses of ThPy-AgNPs, which upon conjugating with Cu(I) ions damaged the cellular walls and disrupted the morphology of the microbe (
Table 1 and
Figure 3). The safe Cu(I) accumulation dosage for
E. coli ATCC 8739 is found to be less than 40 µg/mL in which the cells can digest the Cu(I) to regulate the metabolic system. The MICs were calculated for thiopyridine and ThPy-AgNPs with and without Cu(I) ions by using the inhibition zone method as mentioned in the Methods section. Minimum inhibitory concentration of thiopyridine is calculated to be 200 µg/mL, whereas for ThPy-AgNPs it is obtained at 100 µg/mL.
Inductively coupled plasma (ICP) spectroscopy analysis (
Table 2) showed that
E. coli contained 0.167 ppm Cu(I) in blank samples, which strengthens our hypothesis that copper is used in the metabolism of bacteria. Different Cu(I) amounts were incubated with
E. coli, and it can be clearly observed that at 30 to 40 ppm of test samples, the amount entering the cells of the sample increased suggesting the effective interaction of ThPy-AgNPs and Cu(I). However, at concentrations higher than 40 ppm of Cu(I), it was toxic and started to kill the bacteria. Therefore, the number of nanoparticles entering the cells declined, which further dropped down to only 1.582 ppm at 100 ppm test nanoparticles. While at 100 ppm in the absence of Cu(I), only 0.009 ppm nanoparticles were infused in the cells.
Atomic force microscopy images of control
E. coli showed a smooth cell surface with no ruptures or indentations as displayed in
Figure 2A.
Figure 2B depicts the image of
E. coli treated with 30 µg/mL (below the MIC) Cu(I), and it is clearly evident that Cu(I)-treated cells are healthier and contain smoother surface as compared to control cells. This is due to the fact that at non-cytotoxic dosage of Cu(I) ions, these ions are used in the metabolism of
E. coli.
Escherichia coli cultures were also treated with thiopyridine alone (MIC, 200 µg/mL), and cell morphology was examined via AFM with variable incubation times. The images revealed a roughness in the surface after 4 hours (
Figure 2C -
E), while the cellular degradation increased with time, and after 8 hours, the cells were degraded. Since the unconjugated AgNPs demonstrated poor antibacterial efficiency as reported in our previous study (
16), their role as cytotoxic agents against
E. coli was ruled out. Furthermore, to balance the effect of Cu(I)-mediated infusion of nanoparticles in
E. coli, we incubated Cu(I)-pretreated cells with thiopyridine, which showed no difference in cell morphology as compared to ligand used alone. Hence, AFM analysis was found to be in complete agreement with the MIC data. ThPy-AgNPs were found to destroy
E. coli more effectively (MIC, 100 µg/mL) compared to thiopyridine alone (MIC, 200 µg/mL) within 4 hours (
Figure 3).